Water 2013, 5(3), 1346-1365; doi:10.3390/w5031346
Review

Pharmaceuticals in the Built and Natural Water Environment of the United States

1 Chemistry Program, College of Arts and Sciences, Grand Canyon University, Phoenix, AZ 85017, USA 2 Center for Environmental Security, Biodesign Institute at Arizona State University, 781 E. Terrace Road, P.O. Box 875904, Tempe, AZ 85287-5904, USA 3 Security and Defense Systems Initiative, Arizona State University, Tempe, AZ 85287-5904, USA 4 Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
* Author to whom correspondence should be addressed.
Received: 22 June 2013; in revised form: 8 August 2013 / Accepted: 28 August 2013 / Published: 11 September 2013
(This article belongs to the Special Issue Sustainable Wastewater Treatment and Pollution Control)
PDF Full-text Download PDF Full-Text [321 KB, uploaded 11 September 2013 14:32 CEST]
Abstract: The known occurrence of pharmaceuticals in the built and natural water environment, including in drinking water supplies, continues to raise concerns over inadvertent exposures and associated potential health risks in humans and aquatic organisms. At the same time, the number and concentrations of new and existing pharmaceuticals in the water environment are destined to increase further in the future as a result of increased consumption of pharmaceuticals by a growing and aging population and ongoing measures to decrease per-capita water consumption. This review examines the occurrence and movement of pharmaceuticals in the built and natural water environment, with special emphasis on contamination of the drinking water supply, and opportunities for sustainable pollution control. We surveyed peer-reviewed publications dealing with quantitative measurements of pharmaceuticals in U.S. drinking water, surface water, groundwater, raw and treated wastewater as well as municipal biosolids. Pharmaceuticals have been observed to reenter the built water environment contained in raw drinking water, and they remain detectable in finished drinking water at concentrations in the ng/L to μg/L range. The greatest promises for minimizing pharmaceutical contamination include source control (for example, inputs from intentional flushing of medications for safe disposal, and sewer overflows), and improving efficiency of treatment facilities.
Keywords: drinking water; sewage sludge; pharmaceuticals; review

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Deo, R.P.; Halden, R.U. Pharmaceuticals in the Built and Natural Water Environment of the United States. Water 2013, 5, 1346-1365.

AMA Style

Deo RP, Halden RU. Pharmaceuticals in the Built and Natural Water Environment of the United States. Water. 2013; 5(3):1346-1365.

Chicago/Turabian Style

Deo, Randhir P.; Halden, Rolf U. 2013. "Pharmaceuticals in the Built and Natural Water Environment of the United States." Water 5, no. 3: 1346-1365.

Water EISSN 2073-4441 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert